MCCE in Assessing Efficacy of Gastro-oesophageal Varices

Status Recruiting

Clinical Trial Summary

This study proposed for the first time the use of MCE to evaluate the efficacy of the treatment of gastroesophageal varices, and compared the examination results with the gold standard to explore whether MCE could replace the electronic gastroscopy as the preferred non-invasive evaluation method for the treatment of gastroesophageal varices.

Clinical Trial Description

Gastro-esophageal varices is one of the complications of portal hypertension in cirrhosis. For patients with moderate to severe varicose veins, international guidelines recommend active treatment, including endoscopic therapy such as endoscopic band ligation (EBL) and interventional radiotherapy such as balloon-occluded retrograde transvenous obliteration (B-RTO)Electronic gastroscopy is the gold standard for the diagnosis of varicose veins at higher blood risk (varicose veins requiring retreatment). However, it is relatively invasive and uncomfortable in the examination process, so that patients with gain-and-compensation cirrhosis are often unwilling to accept it, which is not conducive to the standardized follow-up after the treatment of gastro-esophageal varices.Magnetically controlled capsule endoscopy (MCE) is a non-invasive detection method independently developed in China that covers the whole digestive tract (except colon) mucosa. Patients only need to swallow a capsule endoscope to make repeated observation for many times, and the examination process is painless. It is an ideal method for diagnosing varicose veins with high blood risk (varicose veins that need treatment). Therefore, this study proposed for the first time the use of MCE to evaluate the efficacy of the treatment of gastroesophageal varices, and compared the examination results with the gold standard to explore whether MCE could replace the electronic gastroscopy as the preferred non-invasive evaluation method for the treatment of gastroesophageal varices. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04984863
Study type	Interventional
Source	Ruijin Hospital
Contact	Duowu Zou, M.D.
Phone	+86-13901617608
Email	zdw12125@rjh.com.cn
Status	Recruiting
Phase	N/A
Start date	January 1, 2020
Completion date	June 30, 2022

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04867954` - Development of 4D Flow MRI for Risk Stratification of Variceal Bleeding in Cirrhosis
Not yet recruiting	`NCT04525768` - Gastroesophageal Varices in Cavernoma
Not yet recruiting	`NCT04527666` - Anticoagulation in Gastroesophageal Varices and JAK2 Mutation
Not yet recruiting	`NCT03729921` - Gastric Variceal Ligation Versus Gastric Variceal Obturation for Secondary Prophylaxis of Gastric Varices	N/A
Not yet recruiting	`NCT04543643` - Endoscopic and Microbiological Assessment of the Effect of Carvedilol Combined With Berberine on GOV in Cirrhosis	Phase 3
Terminated	`NCT03910413` - Dual Energy CT as a Noninvasive Method to Screen for Gastroesophageal Varices	N/A
Recruiting	`NCT04692805` - EUS-guided PSE in Combination With EUS-guided Treatment of Varices for Patients With Portal Hypertension	N/A
Recruiting	`NCT02646202` - Scleroligation for Eradication of Gastroesophageal Varices.	Phase 3
Recruiting	`NCT04640350` - Risk Prediction of Bleeding in Liver Cirrhosis by Combi-elastography
Recruiting	`NCT04639323` - Endoscopic Ruler for the Assessment of Variceal Bleeding Risks (CHESS2005)
Recruiting	`NCT02638415` - The Effect of Hepatic Vein Pressure Gradient(HVPG)-Guided Therapy in Cirrhotic Patients With Esophagogastric Varices	Phase 4
Not yet recruiting	`NCT04524650` - Early Diagnosis of Oxaliplatin-induced Portal Hypertension
Recruiting	`NCT04123509` - Non-invasive Method for Predicting the Presence of Gastroesophageal Varices in Patients With Cirrhosis
Completed	`NCT02672319` - EUS-guided Glue Injection for Varices Study	N/A
Recruiting	`NCT04786743` - Timing of Endoscopic Intervention for Acute Variceal Hemorrhage: an RCT	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.